SP
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ·Healthcare·Biotechnology
$5.29
-3.21%
Mkt Cap $509.43M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
Implied Upside
+382.5%
Consensus $25.50 vs current $5.29
NASDAQ·Healthcare·Biotechnology
$5.29
-3.21%
Mkt Cap $509.43M
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
+382.5%
Consensus $25.50 vs current $5.29